يعرض 1 - 20 نتائج من 21,342 نتيجة بحث عن '(( significant ((new decrease) OR (_ decrease)) ) OR ( significant risks decrease ))', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1

    Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA. حسب Mieke L. M. Bentvelzen (21594442)

    منشور في 2025
    "…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA.…"
  2. 2

    Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. حسب Mieke L. M. Bentvelzen (21594442)

    منشور في 2025
    "…The red line represents the significance threshold (<i>P < </i>5 × 10<sup>−8</sup>). …"
  3. 3
  4. 4

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. حسب Jinwei Zhang (462455)

    منشور في 2025
    "…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …"
  5. 5

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  6. 6

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Analysis of FROM dynamics (pre-epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  12. 12

    Analysis of FROM dynamics (post epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  13. 13

    Robustness check. حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  14. 14

    Third. حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  15. 15

    Analysis of TO dynamics (in-epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  16. 16

    Analysis of TO dynamics (pre-epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  17. 17

    Descriptive statistical analysis of the total sample. حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  18. 18

    Second. حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  19. 19

    Dynamics of net spillage in the first stage (pre-epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"
  20. 20

    Dynamics of net spillage in the third stage (post epidemic). حسب Cuicui Liu (1496260)

    منشور في 2024
    الموضوعات: "…phenomenon intensified significantly…"